Cancer Research Research Funding  Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Czarnomska, A.
Right arrow Articles by Demant, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Czarnomska, A.
Right arrow Articles by Demant, P.
[Cancer Research 63, 4533-4537, August 1, 2003]
© 2003 American Association for Cancer Research


Molecular Biology and Genetics

Opposite Effects of Modifiers of the ApcMin Mutation in Intestine and Mammary Gland1

Alina Czarnomska, Elzbieta Krysiak, Joanna Piskorowska, Miroslawa Sitarz, Kazimiera Pysniak, Tomás Pilcík and Peter Demant2

Department of Genetics and Laboratory Animal Breeding, Maria Sklodowska–Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland [A. C., E. K., J. P., M. S., K. P.]; Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands [P. D.]; and Laboratory of Cellular and Molecular Immunology, Institute of Molecular Genetics, Academy of Sciences of Czech Republic, Prague, Czech Republic [T. P.]

Patterns of tumor susceptibility in different organs are widely divergent in mouse strains: one strain may be highly susceptible to tumors in one organ but resistant in another organ, whereas another strain may exhibit the opposite pattern (P. Demant, Semin. Cancer Biol., 3: 159–166, 1992). Therefore, susceptibility to tumors in different organs is assumed to be controlled by different sets of genes. On the other hand, many oncogenes and tumor suppressor genes are mutated in tumors from different organs, indicating that similar tumorigenic pathways operate in various tissues. To obtain insight into the interactions of susceptibility genes with one of such pathways, we compared tumorigenesis in intestine and mammary gland in recombinant congenic strains (RCSs) carrying the ApcMin mutation, affecting the Wnt pathway. The presence of ApcMin increased considerably the incidence of intestinal and mammary tumors. The individual RCSs differed in the number and latency of ApcMin-induced intestinal and mammary tumors and histological type of the latter. Unexpectedly, the strain distribution of susceptibility to the intestinal and mammary tumors in the ApcMin-bearing mice was opposite in the RCSs; the strains most susceptible for intestinal tumors were most resistant to mammary tumors and vice versa. This suggests that a set of genes controls the impact of the ApcMin mutation in both organs but with opposite effects. Elucidation of the basis of the observed strain differences in organ-specific Wnt pathway-mediated tumorigenesis will help to understand the interactions between germ-line encoded allelic differences in susceptibility genes and the spectrum of somatic mutations in tumor cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Wang, D. Teske, A. Tess, R. Kohlhepp, Y. Choi, C. Kendziorski, and A. R. Moser
Identification of Novel Modifier Loci of ApcMin Affecting Mammary Tumor Development
Cancer Res., December 1, 2007; 67(23): 11226 - 11233.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
N. Suraweera, A. Latchford, A. McCart, P. Rogers, S. Spain, O. Sieber, R. Phillips, I. Tomlinson, and A. Silver
Pregnancy does not influence colonic polyp multiplicity but may modulate upper gastrointestinal disease in patients with FAP
J. Med. Genet., August 1, 2007; 44(8): 541 - 544.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. F. Di Pace, S. Massa, O. G. Ribeiro, W. H. K. Cabrera, M. De Franco, N. Starobinas, M. Seman, and O. C. M. Ibanez
Inverse genetic predisposition to colon versus lung carcinogenesis in mouse lines selected based on acute inflammatory responsiveness
Carcinogenesis, August 1, 2006; 27(8): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. Mullerova and P. Hozak
Use of Recombinant Congenic Strains in Mapping Disease-Modifying Genes
Physiology, June 1, 2004; 19(3): 105 - 109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.